Article
Drastic Reduction of Turnaround Time After Implementation of a Fully Automated Assay for RAS-BRAF Mutations in Colorectal Cancer: A Pilot Prospective Study in Real-life Conditions.
Pathology oncology research : POR - 1 Oct 2020
Rossat Stéphane, Perrier Hervé, Lefevre Marine, Louvet Christophe, Le Berre Nathalie, Chamois Jérôme, Dorel Maryline, Vacque Daniel, Guillaudeau Angélique, Genet Dominique, Maillet Evelyne, Triby Simon, Sabourin Jean-Christophe
Abstract excerpt
In some situations, there is a need for rapid mutation tests for guiding clinical decisions and starting targeted therapies with minimal delays. In this study we evaluated the turnaround time before and after the implementation of a fully automated multiplex assay for KRAS and NRAS/BRAF mutation tests (Idylla™ platform, Biocartis) in metastatic colorectal cancer. The objective of this project was to compare the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.